BioCentury
ARTICLE | Company News

Regulus Therapeutics Inc, AstraZeneca deal

April 13, 2015 7:00 AM UTC

Regulus’ partner AstraZeneca selected RG-125 ( AZD4076) as the first compound it intends to take into the clinic under the companies’ 2012 deal. AZ plans to start a Phase I trial by year end of the G...